If you liked this article you might like

Bankrupt Introgen Seeks Reincarnation IPO in Biotech Bubble
Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing
The Biotech Bubble Debate: Solid Science vs. Sky-High Valuations
Poof! Biotech's 2014 Outperformance is Gone